A Trial With Humanized TNFα Monoclonal Antibody Injection by Single Dose and Dose Escalation in Healthy Subjects

NCT02460393 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Humanized TNFα monoclonal antibody
OTHER: placebo

Sponsor

Shenyang Sunshine Pharmaceutical Co., LTD.